Unknown

Dataset Information

0

Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors

ABSTRACT:

SUBMITTER: De Boni L 

PROVIDER: S-EPMC12937152 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Precision medicine in metastatic colorectal cancer: targeting <i>KRAS</i> G12C mutation.
| S-EPMC11535780 | biostudies-literature
Unknown Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors.
| S-EPMC6966533 | biostudies-literature
Unknown Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis.
| S-EPMC6135591 | biostudies-literature
Unknown Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy.
| S-EPMC9864058 | biostudies-literature
Unknown Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer.
| S-EPMC8762933 | biostudies-literature
Unknown Precision medicine and metabolic syndrome.
| S-EPMC9937665 | biostudies-literature
Unknown Distinct metabolic preference of atypical KRAS mutant.
| S-EPMC7661907 | biostudies-literature
Unknown A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS.
| S-EPMC7319959 | biostudies-literature
Unknown Genomics-Driven Precision Medicine in Pediatric Solid Tumors.
| S-EPMC10000495 | biostudies-literature
Unknown Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in <i>KRAS</i>-mutant lung cancer.
| S-EPMC10031260 | biostudies-literature